FDA Inspection
Synexus Clinical Research US, Inc.Synexus Clinical Research US, Inc. – FDA Inspection, May 11, 2017
Record Details
This FDA Inspection record concerns Synexus Clinical Research US, Inc., with an inspection on May 11, 2017, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 8e120362-1646-427b-b6d4-19ce12823d60
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1015462
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Synexus Clinical Research US, Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 4, 2017 | Not classified | Dallas District Office |
Other documents for Synexus Clinical Research US, Inc.
- FDA Inspection 1029957 - 2017-08-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.